Table 2.

Prevalence of highlighted anamnestic information. “Marked” questions were highlighted by the patients during self-assessment in case of doubts or uncertainties. “Red flags” were automatically highlighted by the system. These items were addressed explicitly during the individual patient briefing prior to the examination

	total (%)
Study collective	n = 292
Total “marked” questions	n = 76 (26%)
Most frequently “marked” questions
- Do you have a history of malignant diseases?	n = 12 (4.1%)
- Which body region will be examined?	n = 11 (3.8%)
- Do you have a history of CT examinations?	n = 10 (3.4%)
Total “Red flag” questions	n = 203 (69.5%)
Severe pain symptoms	n = 10 (3.4%)
Claustrophobia	n = 12 (4.1%)
History of contrast agent side effects	n = 7 (2.4%)
Thyroid pathology	n = 31 (10.6%)
Scheduled or current radio-iodine therapy	n = 1 (0.3%)
Intake of thyroid medication	n = 25 (8.6%)
- Levothyroxine	n = 20 (6.8%)
- Iodide	n = 4 (1.4%)
- Carbimazol	n = 1 (0.3%)
Kidney disease	n = 42 (14.4%)
Pathologic creatinine values >1.2 mg/dl	n = 10 (3.4%)
Missing creatinine values	n = 97 (33.3%)
Metabolic disease	n = 40 (13.6%)
- Diabetes mellitus	n = 25 (8.6%)
- Metformin	n = 16 (5.5%)
Infectious diseases	n = 14 (4.8%)
- HIV/AIDS	n = 3 (1.0%)
- Tuberculosis	n = 3 (1.0%)
- Hepatitis (A-D)	n = 4 (1.4%)
Pregnancy and/or breastfeeding	n = 0 (0%)